A detailed history of Nikko Asset Management Americas, Inc. transactions in Burning Rock Biotech LTD stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 591,428 shares of BNR stock, worth $3.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
591,428
Previous 667,065 11.34%
Holding current value
$3.67 Million
Previous $620,000 30.48%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$0.68 - $0.97 $51,433 - $73,367
-75,637 Reduced 11.34%
591,428 $431,000
Q2 2023

Aug 14, 2023

BUY
$2.15 - $3.16 $23,542 - $34,602
10,950 Added 1.67%
667,065 $1.43 Million
Q1 2023

May 03, 2023

SELL
$2.16 - $3.47 $125,085 - $200,947
-57,910 Reduced 8.11%
656,115 $1.84 Million
Q4 2022

Feb 13, 2023

SELL
$1.73 - $2.95 $48,102 - $82,024
-27,805 Reduced 3.75%
714,025 $1.61 Million
Q3 2022

Nov 14, 2022

SELL
$2.39 - $3.96 $26,705 - $44,249
-11,174 Reduced 1.48%
741,830 $1.71 Million
Q2 2022

Aug 04, 2022

SELL
$1.75 - $10.44 $2.4 Million - $14.3 Million
-1,373,509 Reduced 64.59%
753,004 $2.2 Million
Q1 2022

May 06, 2022

BUY
$6.7 - $10.23 $6.39 Million - $9.76 Million
953,971 Added 81.36%
2,126,513 $20 Million
Q4 2021

Feb 08, 2022

BUY
$9.43 - $17.14 $2.39 Million - $4.34 Million
253,117 Added 27.53%
1,172,542 $12,000
Q3 2021

Nov 09, 2021

BUY
$17.37 - $27.92 $2.74 Million - $4.41 Million
157,922 Added 20.74%
919,425 $16.1 Million
Q2 2021

Aug 09, 2021

SELL
$26.14 - $37.45 $2.66 Million - $3.81 Million
-101,840 Reduced 11.8%
761,503 $21.7 Million
Q1 2021

May 03, 2021

BUY
$23.5 - $39.58 $10.9 Million - $18.3 Million
462,051 Added 115.14%
863,343 $23.2 Million
Q4 2020

Feb 11, 2021

BUY
$22.55 - $30.87 $9.05 Million - $12.4 Million
401,292 New
401,292 $9.27 Million

Others Institutions Holding BNR

About Burning Rock Biotech Ltd


  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $652M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.